granisetron has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, H; Babaya, K; Hayashi, Y; Hiramatsu, T; Hirao, YK; Kaneko, Y; Maruyama, Y; Matsuki, H; Momose, H; Natsume, O; Ohara, S; Okajima, E; Ozono, S; Sasaki, K; Shiomi, T; Tabata, S; Takashima, K; Watanabe, S; Yamada, K; Yoshikawa, M | 1 |
1 trial(s) available for granisetron and Prostatic Neoplasms
| Article | Year |
|---|---|
[A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Na
Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Male; Granisetron; Humans; Kidney Neoplasms; Male; Methylprednisolone; Middle Aged; Nausea; Prostatic Neoplasms; Registries; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting | 1997 |